Lv1
38 积分 2024-01-04 加入
Menin-MLL protein–protein interaction inhibitors: a patent review (2021-present)
7小时前
已完结
LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia
5天前
已完结
Sickle cell trait (sicklemia)
5天前
已关闭
Cancer biology and the principles of targeted cancer drug discovery
6天前
已完结
CBL-B – An upcoming immune-oncology target
7天前
已关闭
In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
21天前
已完结
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
25天前
已完结
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity
25天前
已完结
Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756)
29天前
已完结
Protein Degradation as a Therapeutic Strategy: The Promise and Progress of Targeted Protein Degraders
29天前
已完结
皖公网安备34019202002308
